{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-018482","form_type":"8-K","ticker":"FLNA","cik":"0001069530","company_name":"FILANA THERAPEUTICS, INC.","filed_at":"2025-05-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.406909+00:00","generated_at":"2026-05-20T09:58:52.875844+00:00","sec_items":["5.02","5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cassava shareholders reject board declassification; director pay raised","bullets":["Proposal to reduce board classification from 3 to 2 classes failed despite 91% of votes cast in favor, lacking 66 2/3% of outstanding shares.","Non-employee director annual cash retainer increased from $10,000 to $40,000; Board Chair gets additional $30,000.","Annual stock option grant for continuing directors raised from 10,000 to 26,500 shares; initial grants rise to 53,000.","Audit, Compensation, and Nominating Committee chairs receive $15,000, $10,000, and $8,000 annual cash fees respectively.","Two directors elected: Robert Anderson, Jr. (5.64M for) and Michael J. O'Donnell (4.54M for) to three-year terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-018482","json":"https://secwatch.observer/filing/0001437749-25-018482.json","markdown":"https://secwatch.observer/filing/0001437749-25-018482.md","text":"https://secwatch.observer/filing/0001437749-25-018482.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925018482/0001437749-25-018482-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925018482/sava20250523_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T09:58:52.875844+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}